A cardinal feature of an adaptive immune response is its ability to generate long-lasting populations of memory T cells (1) (2) (3) . Memory T cells are specific to the Ag encountered during a primary immune response, and they respond rapidly and vigorously upon reencounter with the same Ag. They are resistant to the conventional costimulation blockade (4 -7), although susceptible to 4 -1BB and OX40 costimulation blockade (8, 9) , and they hinder allograft survival or tolerance induction (10 -19) . However, their migratory pathways and functional requirements for chemokines are not well understood.
Chemokines are chemotactic cytokines that are involved primarily in cell recruitment and activation (20 -23) . MCP-1 or CCL2 is a main monocyte chemoattractant in vivo (24 -26) . It also attracts NK cells as well as activated/memory T cells in vitro (27, 28) , as the latter highly express CCR2, the receptor for MCP-1 (21, 29) . Moreover, MCP-1 plays an important role in T cell differentiation into Th2 responses (30, 31) . CCR2-deficient mice are defective in monocyte migration and Th1 responses (32) (33) (34) , susceptible to intracellular pathogen infections (35) , and resistant to the development of experimental autoimmune encephalomyelitis (36, 37) . In contrast, chemokines and chemokine receptors mediate leukocyte recruitment and the rejection of allografts (38 -42) . Blocking the MCP-1/CCR2 chemokine pathway prolongs allograft survival (43) (44) (45) (46) . However, it is unclear whether MCP-1 is required for allograft rejection mediated by memory T cells. In this study, we investigated the role of MCP-1 in the generation, migration, and function of donor-specific memory CD8
ϩ T cells and demonstrated that MCP-1 plays an important role in the generation and survival of memory CD8 ϩ T cells. Interestingly, the survival of effector memory (T EM ) 4 , but not central memory (T CM ), CD8 ϩ T cells was reduced without MCP-1, whereas the homeostatic proliferation of T CM , but not T EM , CD8
ϩ cells was weakened in MCP-1 Ϫ/Ϫ mice. Moreover, the function and migration of T CM , but not T EM , CD8
ϩ cells was significantly impaired in the absence of MCP-1.
Materials and Methods

Mice
2C TCR-transgenic C57BL/6 mice on a recombination activating gene-1 knockout (Rag1 Ϫ/Ϫ ) background (2C Rag Ϫ/Ϫ ) were generated by backcrossing 2C transgenic mice onto Rag1 Ϫ/Ϫ mice (The Jackson Laboratory) (6, 12) . MCP-1 Ϫ/Ϫ mice (B6 background) were ordered from The Jackson Laboratory. Wild-type (WT) BALB/c and C57BL/6 mice were purchased from the National Cancer Institute (National Institutes of Health, Bethesda, MD). All mice were housed in a specific pathogen-free environment, and all animal experiments and protocols were approved by the Animal Care and Use Committee of the University of Texas Health Center. ϩ T cells (5 ϫ 10 6 ) were then adoptively transferred to B6 mice that were immunized i.p. with irradiated BALB/c splenocytes. 2C CD8 ϩ 1B2 ϩ memory T cells were finally detected by staining with anti-CD8-PE, 1B2, and rat anti-mouse IgG1-FITC and enumerated by a FACSCalibur (BD Biosciences) 10 wk after the immunization. CD8 ϩ T cell memory phenotype was further confirmed by staining with anti-CD62L-APC or anti-CD44-APC (BD Pharmingen) as described previously (6 
Memory T cell generation, preparation, and phenotyping
2C cell proliferation in vitro and supernatant IFN-␥ measurement
Naive or memory 2C cells (1 ϫ 10 4 /well), isolated by FACS cell sorting from lymph nodes or livers and kidneys of recipient mice, were cultured with irradiated BALB/c spleen cells (1 ϫ 10 4 /well) in 96-well plates (Corning Costar) in complete RPMI 1640 medium (10% FCS, 2 mM of glutamine, 100 U/ml penicillin, and 100 g/ml streptomycin). Cells were cultured for 24 h and pulsed with [ 3 H]thymidine for last 6 h. Cells were then harvested and analyzed by a scintillation counter (PerkinElmer). To measure IFN-␥ production by 2C memory cells, the same cells were cultured for up to 24 h, and IFN-␥ level in the supernatant was detected by a mouse cytokine ELISA kit according to the manufacturer's instructions (Invitrogen).
Isolation of graft-infiltrating cells
Graft-infiltrating cells were isolated as described previously (6, 12) . Briefly, the kidneys that harbored islet allografts were perfused in situ with heparinized 0.9% saline. They were then minced and digested at 37°C for 30 min in 20 ml RPMI 1640 medium containing 5% FCS and 350 U/ml collagenase (Sigma-Aldrich). To clear the debris, cell suspensions were rapidly passed down a 70-m cell strainer, then mixed with Percoll solution (Sigma-Aldrich) to a concentration of 30% and centrifuged at 2000 rpm for 15 min at room temperature. The pellet was resuspended and stained with related Abs before analysis.
Analysis of T cell proliferation in vivo by BrdU labeling and apoptosis by a TUNEL method.
Recipient mice were pulsed i.p. with 0.8 mg of BrdU (Sigma-Aldrich) 6 days after islet transplantation. Twenty-four hours later, renal graft-infiltrating cells or renal draining lymph node cells were isolated and stained with anti-CD8-PE and 1B2, followed by rat anti-mouse IgG1-biotin and streptavidin-PerCP. Cells were then fixed in 70% ethanol followed by 1% paraformaldehyde and incubated with 50 U/ml DNase I (Sigma-Aldrich). Cells were finally stained with anti-BrdU-FITC (BD Biosciences) and analyzed by a four-color FACSCalibur (6, 12) . To detect cell apoptosis, graftinfiltrating cells were fixed in 2% paraformaldehyde, permeabilized with 0.1% Triton X-100 solution, and labeled with fluorescein-tagged dUTP by the TUNEL method according to the manufacturer's instructions (Roche Applied Science) (6, 12) . To detect the homeostatic proliferation and apoptosis of 2C memory cells during maintenance phase (see Fig. 5 ), immunized mice were pulsed with 0.8 mg of BrdU 4 or 8 wk after the immunization. Cells containing 2C memory cells were then isolated from mesenteric lymph nodes (T CM ) and livers (T EM ), stained, and analyzed by the FACS.
Treatment of mice with neutralizing anti-MCP-1 Ab
To neutralize MCP-1 in vivo, WT recipient mice or MCP-1 Ϫ/Ϫ recipients that received islet grafts from WT donors were treated with anti-MCP-1 Ab or isotype control Ab (R&D System) via i.p. injection of 0.2 mg on days 0, 2, 4, 6, and 8 after i.p. immunization for 2C memory cell generation (see Fig. 1 ), on days 4, 6, 8, and 10 after islet transplantation for allograft rejection by 2C memory cells (see Fig. 6 ), or on days 0, 2, and 4 after islet transplantation for migration and apoptosis experiments (see Figs. 3 and 4) .
Statistical analysis
The analysis of allograft survival data was performed using the KaplanMeier log-rank test. Comparison of means was conducted using ANOVA. ϩ T cells were isolated and quantified by FACS analysis.
Results
Impaired
As shown in Fig. 1A , we found that the percentages of 2C memory CD8 ϩ 1B2 ϩ T cells in mesenteric lymph nodes (mLN), spleens, and livers from MCP-1 Ϫ/Ϫ mice were much lower than those from WT mice (0.5 vs 1.6% in mLN, 0.4 vs 1.3% in the spleen, and 0.3 vs 0.9% in the liver). Similarly, the percentages of 2C memory CD8 ϩ 1B2 ϩ T cells from WT mice treated with neutralizing anti-MCP-1 Ab were lower than those from untreated WT mice (0.7 vs 1.6% in mLN, 0.6 vs 1.3% in the spleen, and 0.4 vs 0.9% in the liver). To perform statistical analysis of memory T cell generation, the absolute cell number was calculated on a per-organ basis as shown in Ϫ/Ϫ recipients that were not immunized. There were much fewer 2C cells (Ͻ0.3%) detected in both lymphoid and nonlymphoid organs of naive recipients, and there was also no significant difference in the percentage of 2C cells between WT and MCP-1 Ϫ/Ϫ (Fig. 1D ). The CD8 ϩ 1B2 ϩ 2C cells generated in immunized murine recipients were confirmed to be memory T cells because 2C cells derived from lymph nodes were mainly CD44 high and CD62L high , a T CM phenotype, while 2C cells derived from liver tissues were mainly CD44 high and CD62L low , a T EM phenotype (Fig. 1B) , as also described previously (6, 47, 48) . It is noteworthy that very few 2C memory cells were detected in the bone marrow cells of immunized mice in our allogeneic murine system (our unpublished observation). Taken together, these data suggest that MCP-1 plays an important role in supporting the generation of both T EM and T CM CD8 ϩ cells.
Memory CD8 ϩ T cells, generated in the absence of MCP-1, are functionally intact in vitro
Memory CD8
ϩ T cells generated under certain conditions are functionally impaired (18) . In addition to their reduced number, memory T cells generated in the absence of MCP-1 also could be functionally impaired. To study whether MCP-1 is required for the generation of functional memory CD8 ϩ T cells, 2C naive CD8 ϩ cells were transferred to mice that were immunized with BALB/c splenocytes 1 day later as described in Fig. 1 . Ten weeks later, 2C T EM and T CM memory cells, generated in the presence or absence of MCP-1, were isolated and restimulated with irradiated BALB/c splenocytes in vitro. IFN-␥ levels in the supernatant were then measured by ELISA, and 2C cell proliferation was measured by ϩ T cells generated in the absence of MCP-1. 2C memory cells were generated as described in Fig. 1 (Fig. 2B ). These findings suggest that the absence of MCP-1 impairs the generation of memory CD8 ϩ T cell number but not their function. In other words, memory CD8 ϩ T cells, although reduced in number in the absence of MCP-1, are functionally intact in vitro once they are already generated. It is unclear whether these memory cells, generated in the absence of MCP-1, can function normally in vivo. Their limited availability due to severely reduced numbers makes it very difficult to perform in vivo experiments.
Lack of homing of T CM , but not T EM , cells to an inflammatory site in the absence of MCP-1
To examine whether MCP-1 is required for the migration of memory T cells to an inflammatory site, WT or MCP-1 Ϫ/Ϫ mice were transplanted with BALB/c islets under the kidney capsule and received an equal number of 2C memory cells. MCP-1 Ϫ/Ϫ recipients were also treated with anti-MCP-1 Ab to neutralize a small amount of MCP-1 released by islet allografts from BALB/c donors, as islet allografts have been shown to be capable of producing the chemokine MCP-1 (43, 44, 49) . One and 2 days later, renal graftinfiltrating cells were isolated and 2C cells were quantified by FACS analysis. As shown in 
Comparable proliferation and apoptosis of infiltrating memory CD8 ϩ T cells in the grafts of WT and MCP-1-deficient mice
Although our data demonstrate a reduced homing of T CM , but not T EM , cells, it is unclear whether both subsets of memory cells undergo a similar expansion and apoptosis after they migrate to an inflammatorysite. recipient mice that received BALB/c islet allografts under the kidney capsule 1 day later. MCP-1 Ϫ/Ϫ recipient mice were also treated with anti-MCP-1 Ab to neutralize a small amount of MCP-1 produced by islet allografts. Seven days later, graft-infiltrating cells were isolated and analyzed for 2C T cell proliferation by the BrdU uptake and for their apoptosis by a TUNEL method (6, 12) . As shown in Fig. 4A , the absence of MCP-1 did not suppress 2C memory cell proliferation in vivo compared with the presence of MCP-1 in WT mice (BrdU-positive: T EM : 22 Ϯ 3% vs 23 Ϯ 2%, and T CM : 27 Ϯ 4% vs 30 Ϯ 3%, both p Ͼ 0.05). In contrast, as shown in Fig. 4B , the absence of MCP-1 in MCP-1 Ϫ/Ϫ recipients also did not significantly alter apoptotic rates of 2C memory cells compared with the presence of MCP-1 in WT mice (TUNEL-positive: T EM : 8 Ϯ 2% vs 7 Ϯ 1%, and T CM : 6 Ϯ 1% vs 5 Ϯ 0%, both p Ͼ 0.05). These results suggest that neither T EM nor T CM memory T cells require MCP-1 for their proliferation or apoptosis once they have migrated to an inflammatory site. Moreover, the numbers of 2C memory/effector cells infiltrating grafts were also calculated. We found that 2C cell numbers remained lower in MCP-1 Ϫ/Ϫ mice than in WT mice (11.7 Ϯ 1.4 vs 7.1 Ϯ 1.2, p Ͻ 0.05) 7 days after 2C T CM cells were transferred (Fig.  4C) , although there was no difference in 2C cell numbers between WT and MCP-1 Ϫ/Ϫ recipients when 2C T EM cells were transferred (12.5 Ϯ 1.9 vs 11.8 Ϯ 1.7, p Ͼ 0.05). These findings indicate that the migration of T CM , but not T EM , cells to inflamed graft sites remains slow in the absence of MCP-1 7 days after transplantation, although both subsets of memory T cells undergo expansion and apoptosis at a similar pace.
Reduced homeostatic proliferation of T CM CD8 ϩ cells and impaired survival of T EM CD8
ϩ cells in the absence of MCP-1
Although our findings suggest that the overall generation of memory CD8 ϩ T cells is impaired in the absence of MCP-1 10 wk after immunization, it is unclear whether the reduced number of memory CD8
ϩ T cells is also due to their impaired homeostatic proliferation or survival. To answer this question, 2C naive CD8 ϩ T 
Impaired function of T CM , but not T EM , CD8 ϩ cells to reject allografts in the absence of MCP-1
To further determine whether the ability of T EM and T CM CD8 ϩ cells to reject an allograft is weakened in the absence of MCP-1, we used a WT, but not lymphocyte-deficient, murine model of allograft rejection mediated by 2C memory T cells. WT B6 mice were transplanted with BALB/c islets and treated with MR1 (anti-CD154 Ab) to prevent islet allograft rejection. They then received 2C T EM or T CM cells to evoke allograft rejection. As shown in Fig.  6 , the recipients did not reject islet allografts within 100 days unless they received either 2C T EM or T CM cells, because memory T 
Discussion
Using a unique mouse model with transgenic donor-specific CD8 ϩ T cells, we investigated the role for the chemokine MCP-1 in the generation, migration, and function of donor-specific memory CD8 ϩ T cells. We found that the generation of both T CM and T EM CD8 ϩ T cells is severely impaired in the absence of MCP-1. Importantly, the survival of T EM , but not T CM , CD8
ϩ cells was reduced without MCP-1, wheras the homeostatic proliferation of T CM , but not T EM , CD8
ϩ cells was weakened in the absence of MCP-1. However, once they were generated in the absence of MCP-1, the in vitro function of both subsets of memory cells remained intact. Interestingly, the migration of T CM , but not T EM , CD8 ϩ T cells to an inflammatory site was significantly delayed in the absence of MCP-1, whereas both subsets of infiltrating memory T cells underwent expansion and apoptosis in vivo in the presence of MCP-1 at a similar pace to those in the absence of MCP-1. Moreover, the function of T CM CD8 ϩ cells to eliminate a graft was impaired in the absence of MCP-1, whereas the T EM CD8 ϩ cell function to reject a graft was not affected in the absence of MCP-1. Thus, this study for the first time demonstrates that MCP-1 plays an important role in not only the migration but also in the generation and function of memory T cells. This finding therefore has important implications for the induction of transplantation tolerance as well as self-tolerance.
Memory T cells are divided into T CM and T EM cells (50 -52 Ϫ/Ϫ mice remains even 7 days after 2C T CM cell transfer and transplantation, and it is likely due to impaired migration rather than changes in proliferation and death, given that 2C memory/effector cells underwent expansion and apoptosis at a similar pace in MCP-1 Ϫ/Ϫ mice at this time point. Perhaps T CM cells need to be first activated in lymph nodes, and their long-distance trafficking to graft tissues requires the presence of MCP-1, whereas T EM cells can directly migrate to graft tissues in the absence of MCP-1. The chemokines that are essential for T EM cell migration to an inflamed tissue remain to be defined, because MCP-1 is not required for their migration. Therefore, targeting the chemokine MCP-1 alone may not be enough to completely prevent allograft rejection mediated by T EM cells or to induce allograft tolerance. Our data also show that neutralizing MCP-1 during early phase of priming inhibits the generation of both T CM and T EM cells, suggesting that targeting MCP-1 during the early stage of T cell migration and activation is the key to suppressing memory cell-mediated immune responsiveness, because T EM cells are no longer susceptible to MCP-1 blockade once they have been generated.
Although T CM cell migration to inflammatory grafts is significantly delayed, our data have shown that the proliferation and apoptosis of both T CM and T EM cells that are infiltrating grafts are not affected in the absence of MCP-1, indicating that MCP-1 is not required for the expansion and apoptosis of both subsets of memory T cells during the activation/effector phase. This finding also suggests that the delayed islet allograft rejection mediated by T CM cells is likely attributed to their delayed migration to inflamed grafts but not to their impaired effector functions. Importantly, the survival of T EM , but not T CM , CD8 ϩ cells after the effector phase was reduced without MCP-1, suggesting that MCP-1 is important for T EM cell survival during memory cell maintenance phase and that the reduced survival of T EM cells likely contributes to their reduced number or generation in the absence of MCP-1 10 wk after immunization. Interestingly, a new study has recently shown that MCP-1 inhibits T cell apoptosis in vitro induced by growth factor deprivation (53) , suggesting that MCP-1 is important for T cell survival postinflammation or right after the effector phase. In contrast, we found that the homeostatic proliferation of T CM , but not T EM , CD8
ϩ cells was weakened in the absence of MCP-1, ϩ cells (2.5 ϫ 10 5 ) were then adoptively transferred to the recipient mice on day 5 to observe allograft rejection mediated by memory CD8 ϩ T cells. All MCP-1 Ϫ/Ϫ recipient mice were also treated with anti-MCP-1 Ab on days 4, 6, 8, and 10 after islet transplantation to neutralize a small amount of MCP-1 produced by islet allografts. WT (OE, n ϭ 6) or MCP-1 Ϫ/Ϫ (‚, n ϭ 6) recipients that received 2C T EM cells; WT (F, n ϭ 7) or MCP-1 Ϫ/Ϫ (E, n ϭ 7) recipients that received 2C T CM cells; and WT (f, n ϭ 6) or MCP-1 Ϫ/Ϫ (Ⅺ, n ϭ 6) recipients, which received or did not receive 2C naive CD8 ϩ cells as controls, were observed for islet allograft rejection.
suggesting that MCP-1 plays a role in supporting the homeostatic proliferation of T CM cells as well as maintaining sufficient numbers of T CM cells 10 wk after immunization. However, it remains to be elucidated why MCP-1 plays a role in the survival of T EM , but not T CM , CD8 ϩ cells and in the homeostatic proliferation of T CM , but not T EM , CD8 ϩ cells. This difference between T CM and T EM cells is interesting and warrants further investigation.
We studied CD8 ϩ , but not CD4 ϩ , memory T cells in this allogeneic setting because: 1) immune regulation in vivo results in a long-lasting CD8 ϩ memory but in a declining CD4 ϩ memory pool over time (54, 55) , indicating that the CD8 ϩ memory pool may by more important for long-term immunity than is CD4 ϩ memory; 2) memory CD8 ϩ T cells are resistant to the conventional costimulatory blockade (4, 7, 56) and therefore could function in the absence of chemokines; and 3) memory CD8 ϩ T cells can be generated in response to an alloantigen independently of CD4 ϩ T cell help (16) , suggesting that memory CD8 ϩ T cells are independent and may pose a more serious threat to tolerance induction than do their CD4 ϩ counterparts. Our studies demonstrate that the migration and function of T CM , but not T EM , CD8
ϩ cells are impaired in the absence of MCP-1. The role for MCP-1 in the generation, survival, migration, and effector function of memory CD4 ϩ T cells remains to be elucidated.
